share_log
Moomoo 24/7 ·  Apr 24 07:00
Alkermes PLC: Expects to Initiate Vibrance-2, a Planned Phase 2 Study in Patients With Narcolepsy Type 2, in Second Half of 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment